A new small animal model of experimental Legionnaires′ disease is described in which the reconstitution of SCID-Beige mice with human peripheral blood leucocytes permits the in-vivo growth of Legionella pneumophila in the lungs of aerosol-challenged mice. Following infection, viable bacterial counts within the lungs of mice increased from 105 cfu/lung at the time of inoculation to a maximum of 1010 cfu/lung by 48 h post-inoculation. Two types of disease were detected in the lungs of infected SCID-Beige mice. An acute exudative bronchiolitis and bronchopneumonia were seen in the most severely affected mice and, in the less severely affected mice, lesions of subacute or chronic disease were seen with thickening of alveolar walls and consolidation of lung tissue. Human cells did not appear to be involved directly in the pathology but were required for the establishment of infection. Immunohistological staining of lung tissue revealed substantial amounts of bacterial antigen distributed in a pattern similar to that seen in human Legionnaires’ disease.
BaskervilleA.,
FitzgeorgeR. B.,
BrosterM.,
HambletonP.,
DennisP. J. Experimental transmission of Legionnaires’ disease by exposure to aerosols of Legionella pneumophila
. Lancet1981; 2:1389–1390
YoshidaS.,
MizuguchiY. Multiplication of Legionella pneumophila Philadelphia-1 in cultured peritoneal macrophages and its correlation to susceptibility of animals. Can J Microbiol1986; 32:438–442
YamamotoY.,
KleinT. W.,
NewtonC. A.,
WidenR.,
FriedmanH. Growth of Legionella pneumophila in thioglycolate-elicited peritoneal macrophages from A/J mice. Infect Immun1988; 56:370–375
SchaibleU. E.,
GayS.,
MuseteanuC. Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver. Am J Pathol1990; 137:811–820
MeadJ. R.,
ArrowoodM. J.,
SidwellR. W.,
HealeyM. C. Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J Infect Dis1991; 163:1297–1304
MosierD. E.,
GuliziaR. J.,
BairdS. M.,
WilsonD. B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature1988; 335:256–259
JeprasR. I.,
FitzgeorgeR. B.,
BaskervilleA. A comparison of virulence of two strains of Legionella pneumophila based on experimental aerosol infection of guinea-pigs. J Hyg1985; 95:29–38
EdelsteinP. H. Improved semiselective medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimens. J Clin Microbiol1981; 14:298–303
FujioH.,
YoshidaS.,
MiyamotoH.,
MitsuyamaM.,
MizuguchiY. Investigation of the role of macrophages and endogenous interferon-gamma in natural resistance of mice against Legionella pneumophila infection. FEMS Microbiol Immunol1992; 4:183–191
YamamotoY.,
KleinT. W.,
NewtonC.,
FriedmanH. Differing macrophage and lymphocyte roles in resistance to Legionella pneumophila infection. J Immunol1992; 148:584–589
Hoffmann-FezerG.,
KranzB.,
GallC.,
ThierfelderS. Peritoneal sanctuary for human lymphopoiesis in SCID mice injected with human peripheral blood lymphocytes from Epstein-Barr virus-negative donors. Eur J Immunol1992; 22:3161–3166
SahneyN. N.,
LambeB. C.,
SummersgillJ. T.,
MillerR. D. Inhibition of polymorphonuclear leukocyte function by Legionella pneumophila exoproducts. Microb Pathog1990; 9:117–125
ConlanJ. W.,
WilliamsA.,
AshworthL. A. E. Inactivation of human α l-antitrypsin by a tissue destructive protease of Legionella pneumophila
. J Gen Microbiol1988; 134:481–487
MintzC. S.,
MillerR. D.,
GutgsellN. S.,
MalekT.Legionella pneumophila protease inactivates interleukin-2 and cleaves CD4 on human T cells. Infect Immun1993; 61:3416–3421